FindMyRecallSubscribe
Class II: temporary or reversible health riskTerminated

Vann Healthcare Services Tri-mix #4 Recall

Tri-mix #4 (Papaverine 30 mg, Phentolamine 1 mg, Prostaglandin-1 10 mcg/mL), packaged…

Vann Healthcare Services Inc · Glasgow, KY

Risk level
Class II
Reported by FDA
Dec 31, 2014
Recall ID
D-0312-2015
Check your lot numberHow we source this data

Summary

Vann Healthcare Services recalled Tri-mix #4 starting Oct 14, 2014. The FDA classified it as Class II (temporary or reversible health risk) and published enforcement report D-0312-2015 on Dec 31, 2014. Reason: Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility of their products. Status: Terminated.

Why it was recalled

Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility of their products.

Product description

Tri-mix #4 (Papaverine 30 mg, Phentolamine 1 mg, Prostaglandin-1 10 mcg/mL), packaged in 10 mL sterile glass vials, Rx, Vann Healthcare Pharmacy, 1220 N Race Street, Glasgow, KY 42141

Lot numbers, UPCs & expiration codes

Lot #s: 04302014@1; 5 mL vial 05072014@4; 10 mL vial 05212014@2; 10 mL vial 06192014@2; 10 mL vial 08072014@4; 5 mL vial 10022014@4; 10 mL split into 2 - 5 mL vials for two different patients

Where it was sold

KY

What to do if you have this product

  • Compare the lot number and expiration date on your package with the codes above.
  • Don't stop taking a prescription medicine on your own. Call your pharmacist or doctor; they can confirm whether your supply is affected and arrange a replacement.
  • If you have symptoms you think are related, contact your doctor. In an emergency call 911.
  • Report side effects to FDA MedWatch at 1-800-FDA-1088.

Recall details

Recall number
D-0312-2015
Classification
Class II
Status
Terminated
Recall initiated
Oct 14, 2014
FDA report date
Dec 31, 2014
Quantity
7 vials
Recall type
Voluntary: Firm initiated
Recalling firm
Vann Healthcare Services Inc

Original FDA data

Every field from FDA enforcement report D-0312-2015, exactly as published.

Show all FDA fields
City
Glasgow
State
KY
Status
Terminated
Country
United States
Event ID
69633
Address
1220 N Race St
Code information
Lot #s: 04302014@1; 5 mL vial 05072014@4; 10 mL vial 05212014@2; 10 mL vial 06192014@2; 10 mL vial 08072014@4; 5 mL vial 10022014@4; 10 mL split into 2 - 5 mL vials for two different patients
Postal code
42141-3462
Report date
Dec 31, 2014
Product type
Drugs
Recall number
D-0312-2015
Classification
Class II
Recalling firm
Vann Healthcare Services Inc
Product quantity
7 vials
Termination date
Jul 1, 2015
Reason for recall
Lack of Assurance of Sterility: A recent FDA inspection of Vann Healthcare Services facility revealed deficiencies that raise concerns about the pharmacy's ability to consistently assure sterility of their products.
Voluntary / mandated
Voluntary: Firm initiated
Product description
Tri-mix #4 (Papaverine 30 mg, Phentolamine 1 mg, Prostaglandin-1 10 mcg/mL), packaged in 10 mL sterile glass vials, Rx, Vann Healthcare Pharmacy, 1220 N Race Street, Glasgow, KY 42141
Distribution pattern
KY
Recall initiation date
Oct 14, 2014
Initial firm notification
Letter
Center classification date
Dec 19, 2014

How we source this data

Source: U.S. Food and Drug Administration enforcement report D-0312-2015, published Dec 31, 2014. View the source record (openFDA) · FDA enforcement reports

Last checked against FDA data: . Content last changed: .

FindMyRecall is an independent service and is not affiliated with or endorsed by the FDA. This page simplifies the official record; the FDA or manufacturer notice is authoritative, so follow its instructions. Medication information here is not individualized medical advice.

How we source and update recall data · Report incorrect information

Other recent drug recalls